Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.285 USD | +0.48% | -5.39% | +48.07% |
May. 14 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | North American Morning Briefing : More Earnings -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.07% | 224M | |
+49.77% | 57.87B | |
+41.65% | 40.25B | |
-6.81% | 39.94B | |
-5.96% | 28.54B | |
+13.07% | 26.4B | |
-19.92% | 19.33B | |
+32.50% | 12.4B | |
+0.38% | 12.23B | |
+25.51% | 12.2B |
- Stock Market
- Equities
- ACRV Stock
- News Acrivon Therapeutics, Inc.
- Ladenburg Thalmann Downgrades Acrivon Therapeutics to Neutral